# Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor

> **NCT02735928** · NA · COMPLETED · sponsor: **Catholic University of the Sacred Heart** · enrollment: 40 (actual)

## Conditions studied

- Ovarian Epithelial Cancer Recurrent
- Platinum-resistant

## Interventions

- **DEVICE:** Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin

## Key facts

- **NCT ID:** NCT02735928
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2021-06-15
- **Final completion:** 2022-06-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02735928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02735928, "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02735928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*